Sign in

CIK 0001726445

  • Non-accelerated filer
  • Smaller reporting company
Ticker
SEER
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
821153150
Phone
+1 650-453-0000
Business address
3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY, CA, 94065
Former names
Seer Biosciences, Inc.
  1. 4 Grant or award Director acquired 46,886 shares (grant or award)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Planned sale Director sold 12,109 shares at $1.78 ($21,512)
  4. 4 Grant or award Director acquired 58,178 shares (grant or award)
  5. 4 Grant or award Director acquired 58,178 shares (grant or award)
  6. 4 Grant or award Director acquired 58,178 shares (grant or award)
  7. 4 Grant or award Director acquired 58,178 shares (grant or award)
  8. 4 Grant or award Director acquired 58,178 shares (grant or award)
  9. 4 Grant or award Director acquired 58,178 shares (grant or award)
  10. 4 Open-market sale CEO AND CHAIR sold 52,857 shares at $2.03 ($107,421)
  11. 4 Open-market sale CHIEF LEGAL OFFICER sold 12,684 shares at $1.58 ($20,024)
  12. 4 Open-market sale PRESIDENT & CFO sold 12,684 shares at $1.58 ($20,024)
  13. 4 Grant or award CEO AND CHAIR acquired 529,634 shares (grant or award)
  14. 4 Open-market sale President and CFO sold 3,608 shares at $1.67 ($6,015)
  15. 4 Open-market sale Chief Legal Officer sold 8,182 shares at $1.70 ($13,869)
  16. 4 Exercise or conversion CEO, President and Chair acquired 151,764 shares (option exercise)
  17. 4 Open-market buy CEO, President and Chair bought 40,000 shares at $2.45 ($97,968)
  18. 4 Grant or award Director acquired 23,443 shares (grant or award)
  19. 4 Grant or award Director acquired 23,443 shares (grant or award)
  20. 4 Grant or award Director acquired 23,443 shares (grant or award)

Page 3 of 9 · 166 filings